• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Select Medical Holdings Corporation

    5/7/24 4:53:01 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care
    Get the next $SEM alert in real time by email
    S-8 1 tm2413595d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on May 7, 2024

    Registration No. 333-       

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

     

     

    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

     

     

    SELECT MEDICAL HOLDINGS CORPORATION
    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware
    (State of incorporation or organization)
    20-1764048
    (I.R.S. Employer Identification No.)

     

    4714 Gettysburg Road, P.O. Box 2034
    Mechanicsburg, Pennsylvania 17055
    (Address of principal executive offices) (Zip Code)

     

     

     

    SELECT MEDICAL HOLDINGS CORPORATION 2020 EQUITY INCENTIVE PLAN
    (Full title of the Plan)

    Michael E. Tarvin, Esq.
    Senior Executive Vice President, General Counsel and Secretary
    Select Medical Holdings Corporation
    4714 Gettysburg Road
    P.O. Box 2034
    Mechanicsburg, Pennsylvania 17055
    (Name and address of agent for service)

     

     

     

    (717) 972-1100
    (Telephone number, including area code, of agent for service)

     

     

     

    With a copy to:
    Stephen M. Leitzell, Esq.
    Dechert LLP
    Cira Centre
    2929 Arch Street
    Philadelphia, Pennsylvania 19104
    (215) 994-4000

     

    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

     

    Large accelerated filer x Accelerated filer ¨
    Non-accelerated filer ¨ Smaller reporting company ¨

     

    (Do not check if a smaller reporting company)

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”).

     

     

     

     

     

    Registration of Additional Shares

    Pursuant to General Instruction E

     

    Pursuant to General Instruction E of Form S-8, Select Medical Holdings Corporation (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register 4,439,044 additional shares of common stock the Registrant, par value $0.001 per share (“Common Stock”), under the Select Medical Holdings Corporation 2020 Equity Incentive Plan (the “Plan”). Such shares of Common Stock are in addition to the 11,829,534 shares of Common Stock registered on the Registrant’s Form S-8 filed on May 13, 2020 (Commission File No. 333-238231), which is incorporated herein by reference. The 4,439,044 additional shares of Common Stock being registered hereby were approved by the stockholders on April 25, 2024.

     

    Item 8. Exhibits.

     

    Exhibit
    Number
      Exhibit Description
         
    4.3   Select Medical Holdings Corporation 2020 Equity Incentive Plan, incorporated by reference to Exhibit A to Select Medical Holdings Corporation’s Definitive Proxy Statement on Schedule 14A filed on March 4, 2020 (Commission File No. 001-34465).
         
    5.1*   Opinion of Dechert LLP as to the legality of the securities being registered.
         
    23.1*   Consent of PricewaterhouseCoopers LLP.
         
    23.2*   Consent of Dechert LLP (included in Exhibit 5.1).
         
    24.1*   Power of Attorney (included on signature pages to this Registration Statement and incorporated herein by reference).
         
    107*   Filing Fee Table
         

     

    * Filed herewith

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Mechanicsburg, Commonwealth of Pennsylvania, on the 7th day of May, 2024.

     

      SELECT MEDICAL HOLDINGS CORPORATION

     

    By:

    /s/ Michael E. Tarvin

    Michael E. Tarvin

    Senior Executive Vice President, General Counsel and Secretary

     

     

     

     

    POWER OF ATTORNEY

     

    KNOW BY ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David S. Chernow and Michael E. Tarvin, and each of them, as his true and lawful attorney-in-fact and agent, each with the power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any amendments (including post-effective amendments) to this Registration Statement, and to file with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that either of said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature   Title   Date
             
    /s/ Robert A. Ortenzio   Director and Executive Chairman   May 7, 2024
    Robert A. Ortenzio        
             
    /s/ Rocco A. Ortenzio   Director and Vice Chairman   May 7, 2024
    Rocco A. Ortenzio        
             
    /s/ David S. Chernow   Chief Executive Officer    
    David S. Chernow   (Principal Executive Officer)   May 7, 2024
             
    /s/ Michael F. Malatesta   Executive Vice President and Chief Financial    
    Michael F. Malatesta   Officer (Principal Financial Officer)   May 7, 2024
             
    /s/ Christopher S. Weigl   Senior Vice President, Controller and Chief    
    Christopher S. Weigl   Accounting Officer (Principal Accounting Officer)   May 7, 2024
             
    /s/ Russell L. Carson   Director    
    Russell L. Carson       May 7, 2024
             
    /s/ Katherine R. Davisson   Director    
    Katherine R. Davisson       May 7, 2024
             
    /s/ James S. Ely   Director    
    James S. Ely       May 7, 2024
             
    /s/ William H. Frist   Director    
    William H. Frist       May 7, 2024
             
    /s/ Parvinderjit S. Khanuja   Director    
    Parvinderjit S. Khanuja       May 7, 2024
             
    /s/ Thomas A. Scully   Director    
    Thomas A. Scully       May 7, 2024
             
    /s/ Marilyn B. Tavenner   Director    
    Marilyn B. Tavenner       May 7, 2024
             
    /s/ Daniel J. Thomas   Director    
    Daniel J. Thomas       May 7, 2024

     

     

     

     

    Get the next $SEM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEM

    DatePrice TargetRatingAnalyst
    10/8/2025$16.00 → $20.00Outperform
    RBC Capital Mkts
    4/16/2025$25.00Outperform
    Mizuho
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    11/25/2024Buy → Hold
    The Benchmark Company
    8/20/2024$42.00Buy
    BofA Securities
    3/7/2022$47.00 → $42.00Outperform
    RBC Capital
    1/18/2022$40.00 → $35.00Buy
    B of A Securities
    1/18/2022$50.00 → $47.00Outperform
    RBC Capital
    More analyst ratings

    $SEM
    SEC Filings

    View All

    SEC Form PRE 14A filed by Select Medical Holdings Corporation

    PRE 14A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/20/26 5:26:28 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    SEC Form 10-K filed by Select Medical Holdings Corporation

    10-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/19/26 4:48:28 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/19/26 4:41:45 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    5/6/25 6:21:53 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Frist William H. was granted 1,109 shares, increasing direct ownership by 0.36% to 305,172 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    2/13/26 4:35:24 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    New insider Hollenbach John Tyler claimed ownership of 135,084 shares (SEC Form 3)

    3 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    1/6/26 5:33:42 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Executive Vice President Duggan John F. covered exercise/tax liability with 4,865 shares, decreasing direct ownership by 2% to 194,710 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    11/4/25 5:58:19 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

    MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the declaration of a cash dividend. For the fourth quarter ended December 31, 2025, revenue increased 6.4% to $1,396.6 million, compared to $1,312.6 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 203.1% to $63.9 million for the fourth quarter ended December 31, 2025, compared to $21.1 million for the same quarter, prior year. Income from continuing operations, net of tax, incr

    2/19/26 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    PHILADELPHIA EAGLES RENEW DEAL WITH SELECT MEDICAL NAMING NOVACARE REHABILITATION THE TEAM'S OFFICIAL PHYSICAL THERAPY PARTNER

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and the Philadelphia Eagles have announced a multi-year extension of its longstanding 25-year partnership naming NovaCare Rehabilitation as the team's Official Physical Therapy Partner. "We are proud to continue our longstanding founding partner relationship with the Philadelphia Eagles, an organization that shares our passion for excellence and creating unforgettable fan experiences," said Ray Pennacchia, senior vice president, NovaCare Rehabilitation. "Many of those fans also trust NovaCare Rehabilitation for world-class physical therapy throughout the Delaware Valley. This renewed agreement bui

    2/17/26 10:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call

    2/17/26 8:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts reiterated coverage on Select Medical with a new price target

    RBC Capital Mkts reiterated coverage of Select Medical with a rating of Outperform and set a new price target of $20.00 from $16.00 previously

    10/8/25 10:00:36 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Mizuho initiated coverage on Select Medical with a new price target

    Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00

    4/16/25 9:09:30 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00

    2/24/25 7:15:26 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Leadership Updates

    Live Leadership Updates

    View All

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

    MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021.  Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi

    11/2/21 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Financials

    Live finance-specific insights

    View All

    Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

    MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the declaration of a cash dividend. For the fourth quarter ended December 31, 2025, revenue increased 6.4% to $1,396.6 million, compared to $1,312.6 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 203.1% to $63.9 million for the fourth quarter ended December 31, 2025, compared to $21.1 million for the same quarter, prior year. Income from continuing operations, net of tax, incr

    2/19/26 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call

    2/17/26 8:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listen

    1/21/26 4:15:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/14/24 1:22:35 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:31 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:04 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care